363 related articles for article (PubMed ID: 23953920)
1. Acute antibody-mediated rejection after lung transplantation.
Witt CA; Gaut JP; Yusen RD; Byers DE; Iuppa JA; Bennett Bain K; Alexander Patterson G; Mohanakumar T; Trulock EP; Hachem RR
J Heart Lung Transplant; 2013 Oct; 32(10):1034-40. PubMed ID: 23953920
[TBL] [Abstract][Full Text] [Related]
2. C4d detection and histological patterns in the diagnosis of antibody-mediated rejection after lung transplantation: a single-centre study.
Ngo C; Danel C; Duong-Quy S; Dauriat G; Castier Y; Lortat-Jacob B; Mal H; Brugière O; Cazes A
Histopathology; 2019 Jun; 74(7):988-996. PubMed ID: 30636056
[TBL] [Abstract][Full Text] [Related]
3. The role of C4d deposition in the diagnosis of antibody-mediated rejection after lung transplantation.
Aguilar PR; Carpenter D; Ritter J; Yusen RD; Witt CA; Byers DE; Mohanakumar T; Kreisel D; Trulock EP; Hachem RR
Am J Transplant; 2018 Apr; 18(4):936-944. PubMed ID: 28992372
[TBL] [Abstract][Full Text] [Related]
4. Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy.
Frank R; Molina MR; Goldberg LR; Wald JW; Kamoun M; Lal P
Am J Clin Pathol; 2014 Dec; 142(6):809-15. PubMed ID: 25389335
[TBL] [Abstract][Full Text] [Related]
5. Free Airway C4d after Lung Transplantation - A Quantitative Analysis of Bronchoalveolar Lavage Fluid.
Heigl T; Saez-Gimenez B; Van Herck A; Kaes J; Sacreas A; Beeckmans H; Ambrocio GPL; Kwakkel-Van Erp H; Ordies S; Vanstapel A; Verleden SE; Neyrinck AP; Ceulemans LJ; Van Raemdonck DE; Verbeken E; Verleden GM; Vos R; Vanaudenaerde B
Transpl Immunol; 2021 Feb; 64():101352. PubMed ID: 33217540
[TBL] [Abstract][Full Text] [Related]
6. C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study.
Moktefi A; Parisot J; Desvaux D; Canoui-Poitrine F; Brocheriou I; Peltier J; Audard V; Kofman T; Suberbielle C; Lang P; Rondeau E; Grimbert P; Matignon M
Transpl Int; 2017 Mar; 30(3):277-287. PubMed ID: 27992962
[TBL] [Abstract][Full Text] [Related]
7. Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody.
Hodges AM; Lyster H; McDermott A; Rice AJ; Smith JD; Rose ML; Banner NR
Transplantation; 2012 Mar; 93(6):650-6. PubMed ID: 22245878
[TBL] [Abstract][Full Text] [Related]
8. The presence of anti-HLA donor-specific antibodies in lung allograft recipients does not correlate with C4d immunofluorescence in transbronchial biopsy specimens.
Roberts JA; Barrios R; Cagle PT; Ge Y; Takei H; Haque AK; Burns KM; Land GA; Dilioglou S; Bernard DW
Arch Pathol Lab Med; 2014 Aug; 138(8):1053-8. PubMed ID: 24164556
[TBL] [Abstract][Full Text] [Related]
9. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
[TBL] [Abstract][Full Text] [Related]
10. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.
Lobo LJ; Aris RM; Schmitz J; Neuringer IP
J Heart Lung Transplant; 2013 Jan; 32(1):70-7. PubMed ID: 23260706
[TBL] [Abstract][Full Text] [Related]
11. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
[TBL] [Abstract][Full Text] [Related]
12. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
Matignon M; Muthukumar T; Seshan SV; Suthanthiran M; Hartono C
Transplantation; 2012 Sep; 94(6):603-11. PubMed ID: 22932115
[TBL] [Abstract][Full Text] [Related]
13. Antibody-mediated rejection after alemtuzumab induction: incidence, risk factors, and predictors of poor outcome.
Willicombe M; Roufosse C; Brookes P; Galliford JW; McLean AG; Dorling A; Warrens AN; Cook TH; Cairns TD; Taube D
Transplantation; 2011 Jul; 92(2):176-82. PubMed ID: 21637139
[TBL] [Abstract][Full Text] [Related]
14. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
15. Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients.
Zhang Q; Hickey M; Drogalis-Kim D; Zheng Y; Gjertson D; Cadeiras M; Khuu T; Baas AS; Depasquale EC; Halnon NJ; Perens G; Alejos J; Cruz D; Ali N; Shemin R; Kwon M; Fishbein MC; Ardehali A; Deng M; Reed EF
Transplantation; 2018 Oct; 102(10):e431-e438. PubMed ID: 29916988
[TBL] [Abstract][Full Text] [Related]
16. C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody.
Ionescu DN; Girnita AL; Zeevi A; Duquesnoy R; Pilewski J; Johnson B; Studer S; McCurry KR; Yousem SA
Transpl Immunol; 2005 Oct; 15(1):63-8. PubMed ID: 16223674
[TBL] [Abstract][Full Text] [Related]
17. Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.
O'Leary JG; Kaneku H; Demetris AJ; Marr JD; Shiller SM; Susskind BM; Tillery GW; Terasaki PI; Klintmalm GB
Liver Transpl; 2014 Feb; 20(2):218-27. PubMed ID: 24382837
[TBL] [Abstract][Full Text] [Related]
18. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological analyses of transplant glomerulopathy cases.
Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
[TBL] [Abstract][Full Text] [Related]
20. Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.
Bartel G; Wahrmann M; Schwaiger E; Kikić Ž; Winzer C; Hörl WH; Mühlbacher F; Hoke M; Zlabinger GJ; Regele H; Böhmig GA
Transpl Int; 2013 Feb; 26(2):121-30. PubMed ID: 23145861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]